FDA resuming normalized operations but will continue to leverage MRAs

Regulatory NewsRegulatory NewsAudit/inspectionBiotechnologyChemistry, Manufacturing and Controls (CMC)North AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy